A risk for early-onset Alzheimer's disease associated with the APBB1 gene (FE65) intron 13 polymorphism
- 27 March 2003
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 342 (1-2) , 5-8
- https://doi.org/10.1016/s0304-3940(03)00225-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Testing for Population Subdivision and Association in Four Case-Control StudiesAmerican Journal of Human Genetics, 2002
- A candidate molecular mechanism for the association of an intronic polymorphism of FE65 with resistance to very late onset dementia of the Alzheimer type.Human Molecular Genetics, 2002
- Replication validity of genetic association studiesNature Genetics, 2001
- Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologiesExperimental Gerontology, 2000
- Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patientsNeuroscience Letters, 2000
- The Number of Trait Loci in Late-Onset Alzheimer DiseaseAmerican Journal of Human Genetics, 2000
- Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation SpectrumAmerican Journal of Human Genetics, 1999
- The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer typeHuman Genetics, 1998
- Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumJAMA, 1997
- cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 proteinHuman Molecular Genetics, 1996